IQ-AI Limited (IQAI) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Oct 2018 02:58 PM
RNS
Result of EGM and Change of Name
27 Sep 2018 07:00 AM
RNS
IB announce agreement to develop a diagnostic tool
18 Sep 2018 07:00 AM
RNS
Proposed name change and notice of EGM
11 Sep 2018 09:00 AM
RNS
Director/PDMR Shareholding
11 Sep 2018 07:00 AM
RNS
Director/PDMR Shareholding
10 Sep 2018 07:00 AM
RNS
Half-year Report
06 Aug 2018 02:51 PM
RNS
Holding(s) in Company
06 Aug 2018 10:16 AM
RNS
Holding(s) in Company
06 Aug 2018 07:00 AM
RNS
Appointment of CEO to the Operating Subsidiaries
01 Aug 2018 04:28 PM
RNS
Publication of a Prospectus

IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.

IQ-AI share price listed in London at 87p in 1996.

UK 100

Latest directors dealings